BPLPHARMA
Bharat Parenterals financials
- Market cap
- ₹1.0k Cr
- Sector
- Healthcare
Quarterly results
Q1 FY27: revenue down 19.2%, net profit down 309.2% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 72 | 72 | 104 | 116 | 65 −10% | 65 −10% | 100 −4% | 94 −19% |
| EBITDA | -8 | 4 | 2 | 14 | 1 +111% | 2 −52% | -1 −123% | 9 −38% |
| Net profit | -18 | -8 | -9 | -1 | -9 +51% | -10 −23% | -8 +14% | -4 −309% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +6.8% 1Y
1Y: ₹1,409.8 on 10 Sept 2025 → ₹1,505.1. High ₹1,568.8 (8 Sept 2026), low ₹890.5 (2 Feb 2026).
Financials, as filed
Revenue grew 15.9% a year over 2 years, FY24 to FY26. Operating margin narrowed to 4.6%.
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹257 Cr | ₹340 Cr | ₹345 Cr |
| Operating profit | ₹22 Cr | ₹3 Cr | ₹16 Cr |
| Operating margin | 8.7% | 0.8% | 4.6% |
| Interest | ₹3 Cr | ₹13 Cr | ₹13 Cr |
| Depreciation | ₹9 Cr | ₹35 Cr | ₹34 Cr |
| Net profit | ₹11 Cr | ₹-44 Cr | ₹-27 Cr |
| Net margin | 4.1% | -12.8% | -7.9% |
| Cash from operations | ₹-5 Cr | ₹-27 Cr | ₹38 Cr |
| Free cash flow | ₹-108 Cr | ₹-56 Cr | ₹-1 Cr |
| ROCE | 7.0% | -4.0% | -2.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹7 Cr | ₹7 Cr |
| Reserves | ₹138 Cr | ₹160 Cr | ₹177 Cr | ₹191 Cr | ₹324 Cr | ₹315 Cr |
| Borrowings | ₹12 Cr | ₹18 Cr | ₹50 Cr | ₹158 Cr | ₹131 Cr | ₹146 Cr |
| Other liabilities | ₹43 Cr | ₹42 Cr | ₹118 Cr | ₹149 Cr | ₹114 Cr | ₹145 Cr |
| Total liabilities | ₹199 Cr | ₹226 Cr | ₹350 Cr | ₹504 Cr | ₹575 Cr | ₹613 Cr |
| Fixed assets | ₹45 Cr | ₹41 Cr | ₹42 Cr | ₹211 Cr | ₹245 Cr | ₹255 Cr |
| Capital work in progress | ₹0 Cr | ₹26 Cr | ₹99 Cr | ₹25 Cr | ₹30 Cr | ₹35 Cr |
| Investments | ₹43 Cr | ₹11 Cr | ₹0 Cr | ₹0 Cr | ₹5 Cr | ₹6 Cr |
| Other assets | ₹111 Cr | ₹148 Cr | ₹209 Cr | ₹268 Cr | ₹294 Cr | ₹317 Cr |
| Total assets | ₹199 Cr | ₹226 Cr | ₹350 Cr | ₹504 Cr | ₹575 Cr | ₹613 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, the public trimmed −0.85 pp while DIIs added +0.84 pp. The shareholder count shrank 5% to 3,059.
- Promoters
- 67.2%
- FIIs
- 0.1%
- DIIs
- 1.4%
- Public
- 31.3%
Since Jun 2025
- Public −0.85 pp
- DIIs +0.84 pp
- Promoters +0.01 pp
How it drifted, 12 quarters
Over this window promoters fell from 73.8% to 67.2% — −6.6 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 73.8%, DIIs 0.0%, Public 26.1%.Dec '23: Promoters 73.8%, DIIs 0.0%, Public 26.1%.Mar '24: Promoters 73.3%, DIIs 0.0%, Public 26.7%.Jun '24: Promoters 73.3%, DIIs 0.0%, Public 26.7%.Sep '24: Promoters 65.3%, FIIs 0.1%, DIIs 0.6%, Public 34.0%.Dec '24: Promoters 67.2%, FIIs 0.1%, DIIs 0.5%, Public 32.2%.Mar '25: Promoters 67.2%, FIIs 0.1%, DIIs 0.5%, Public 32.1%.Jun '25: Promoters 67.2%, FIIs 0.1%, DIIs 0.5%, Public 32.2%.Sep '25: Promoters 67.2%, FIIs 0.1%, DIIs 0.5%, Public 32.2%.Dec '25: Promoters 67.2%, FIIs 0.1%, DIIs 0.5%, Public 32.2%.Mar '26: Promoters 67.2%, FIIs 0.1%, DIIs 1.1%, Public 31.6%.Jun '26: Promoters 67.2%, FIIs 0.1%, DIIs 1.4%, Public 31.3%.
Who is on the register
Named in the Jun 2026 filing
Every holder of Bharat Parenterals Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Desai Shares And Stock Private Limited | 39.67% | unchanged |
| Himaben Bharatbhai Desai | 13.97% | unchanged |
| Bharatkumar Rameshchandra Desai | 10.76% | unchanged |
| Asoj Soft Caps Pvtltd(Anchor) | 4.94% | unchanged |
| Ashish Kacholia | 1.87% | unchanged |
| Madhulika Agarwal | 1.87% | unchanged |
| Sohini Girish Patel | 1.41% | unchanged |
| Manohar Devabhaktuni | 1.37% | unchanged |
| Bhahim Bharatkumar Desai | 1.29% | unchanged |
| Nikita Bhahim Desai | 1.22% | unchanged |
| Rajasthan Global Securities Private Limited NBFC / DFI | 1.08% | unchanged |
| Varenyam Healthcare Private Limited | 0.24% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Bharat Parenterals Limited
Guides on how to read this kind of business and the numbers that matter.